Results 191 to 200 of about 4,929,883 (200)

First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study

Lancet, The, 2017
Jean-Charles Soria, Alexis B Cortot, Rita Chiari   +2 more
exaly  

Mystery line 1: The sequel

The Leading Edge, 1996
openaire   +1 more source

Advances in the noninvasive diagnosis of melanoma—40 years beyond the ABCDs

Ca-A Cancer Journal for Clinicians
Alexander Witkowski, Milaan Shah, Joanna Łudzik   +2 more
exaly  

THE FULL RESOUNDING LINE.*1

The Lancet, 1925
openaire   +1 more source

Memories of Maurice Line: 1

Interlending & Document Supply, 2005
openaire   +1 more source

Euripides, Bakkhai (lines 1-167)

Literary Imagination, 1999
openaire   +1 more source

51. Baudelaire’s Recueillement, Line 1

The Explicator, 1962
openaire   +1 more source

Lines 1-18: The Proem

1986
openaire   +1 more source

Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study

Lancet, The, 2013
exaly  

The LINE‐1 paradox: Active yet immobile

BioEssays
openaire   +2 more sources